Determination of FGN-1 (an active metabolite of sulindac) in human plasma, urine, and feces by HPLC.
Ray
G F
GF
Kansas City Analytical Services, Inc., Shawnee, KS 66216, USA.
Lanman
R C
RC
Fu
C J
CJ
Paranka
N S
NS
Pamukcu
R
R
Wheeler
S C
SC
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000032:analysis* / Q000302:isolation & purification / Q000493:pharmacokinetics; D002138:Calibration; D002851:Chromatography, High Pressure Liquid; D005243:Feces / Q000737:chemistry; D005965:Glucuronates / Q000032:analysis; D006801:Humans; D006868:Hydrolysis; D008297:Male; D013467:Sulindac / Q000031:analogs & derivatives* / Q000032:analysis / Q000302:isolation & purification / Q000493:pharmacokinetics
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005965:Glucuronates; D013467:Sulindac; C025463:sulindac sulfone